Letrozole (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Letrozole drug offered from Avera McKennan Hospital. This Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | Letrozole |
| SUBSTANCE NAME: | LETROZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-02-17 |
| END MARKETING DATE: | 0000-00-00 |
Letrozole HUMAN PRESCRIPTION DRUG Details:
| Item Description | Letrozole from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/1) |
| START MARKETING DATE: | 2016-02-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-7620_647a695c-4f3d-4450-a345-091b6911698a |
| PRODUCT NDC: | 69189-7620 |
| APPLICATION NUMBER: | ANDA090289 |
Other LETROZOLE Pharmaceutical Manufacturers / Labelers:
